2-(3-Methyl-1,2-oxazol-5-yl)acetic acid → HCID 178511191, compound

HRID 1023223Notes

Reaction equation

HRID 1023223 reaction equation
Cl.Cl.Cl.[O:4]1[C:8]2[CH:9]=[CH:10][CH:11]=[C:12]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH2:27])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[C:7]=2[O:6][CH2:5]1.C[C:29]1[CH:33]=[C:32](CC(O)=O)[O:31][N:30]=1>>[O:4]1[C:8]2[CH:9]=[CH:10][CH:11]=[C:12]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH:27][C:32](=[O:31])[CH2:33][C:29]#[N:30])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[C:7]=2[O:6][CH2:5]1

Participants

3

Reactant 2

HCID 41955322-(3-Methyl-1,2-oxazol-5-yl)acetic acidHCID 178478587HCID 178478587, compound2×

Product 1

HCID 178511191HCID 178511191, compound

Procedure

The title compound, white solid (9 mg, 32%), MS (ISP) m/z=399.5 [(M+H)+], was prepared in accordance with the general method of example 1 from Trans-4-[2-(4-Benzo[1,3]dioxol-4-yl-piperazin-1-yl)-ethyl]-cyclohexylamine hydrochloride (Intermediate A) (25.8 mg, 0.070 mmol) and 2-(3-methylisoxazol-5-yl)acetic acid

Sources & evidence

ORD record
ord-87ec0aeeb21345718aab4a4ca9e5bb50
Source dataset
uspto-grants-2014_05
Patent number
US08722683B2

Reaction notes

Loading…